Transitional Case Management Study

November 16, 2016 updated by: University of California, Los Angeles
To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.

Study Overview

Status

Completed

Detailed Description

To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.

More specifically, the multi-site study will evaluate the effects of a strengths case-management intervention on community-based treatment/service admission, retention, and utilization among inmates released from supervised treatment programs. If the intervention is successful, its wider adoption would increase the likelihood that inmates enter and remain in community services.

The specific aims of this multi-site study are to:

  1. Increase the likelihood that offenders leaving prison (or other supervised setting) with a referral to community aftercare program services enroll in treatment.
  2. Increase the amount of time that such offenders participate in community treatment.
  3. Assist clients to get the services that they need during the first 12 weeks of return to the community.
  4. As a result of the above, reduce relapse and reoffending during and following treatment.
  5. Achieve the above results at a favorable cost-effectiveness ratio.
  6. Encourage closer collaboration between the treatment and criminal justice systems.

Study participants (200 at each site, 25% of will be women) will be recruited in prison (or other confined setting) from inmates who have a referral to community treatment. After informed consent and a baseline interview, they will be randomly assigned to one of two conditions: (1) the Transitional Case Management condition, and (2) the Standard Referral condition (i.e., usual transition/re-entry procedures used by the facility, including a referral to community treatment).

Individual-level outcomes will include (1) treatment admission and participation (based on data collected from programs), (2) drug use, criminal activity, and psychosocial functioning (based on telephone interviews conducted 3 months after the end of the intervention) and (3) recidivism (based on records collected 12 months after the end of the intervention). The study will also assess the impact of the intervention on organizational and system factors (based on information from the case manager, treatment staff, and criminal justice staff) and the cost effectiveness of the intervention.

Study Type

Interventional

Enrollment (Actual)

812

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90025
        • University of California, Los Angeles
    • Connecticut
      • Hartford, Connecticut, United States, 06134
        • Connecticut Department of Mental Health and Addiction Services
    • Kentucky
      • Lexington, Kentucky, United States, 40506
        • University of Kentucky
    • New York
      • New York, New York, United States, 10048
        • National Development and Research Institutes, Inc. (NDRI)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 years or older
  • Participate in a treatment program within a correctional institution (prison, work release, community correctional facility)
  • Have a referral to a community-based substance abuse treatment program (as arranged by correctional staff or treatment staff)
  • Within about 3 months until release
  • Being released to the metropolitan area where case manager activities are being conducted

Exclusion Criteria:

  • Referral to formal case management services in the community (e.g., for offenders with co-occurring disorders)
  • Inability to provide informed consent (as determined by a set of questions about the consent process)
  • Registered sex offender (as determined by the institution)
  • Parole requirements that would prevent participation in the study (e.g., INS hold for deportation)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Treatment admission by three months following parole
Time Frame: Three months
Three months
Treatment retention by three months following parole
Time Frame: Three months
Three months
Drug use at nine months following parole
Time Frame: Nine months
Nine months
Recidivism at nine months following parole
Time Frame: Nine months
Nine months

Secondary Outcome Measures

Outcome Measure
Time Frame
Education and employment at nine months following parole
Time Frame: Nine months
Nine months
HIV risk behaviors at nine months following parole
Time Frame: Nine months
Nine months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael L Prendergast, Ph.D., University of California, Los Angeles
  • Study Director: Jerome Cartier, M.S., University of California, Los Angeles

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2004

Primary Completion (Actual)

April 1, 2006

Study Completion (Actual)

May 1, 2008

Study Registration Dates

First Submitted

December 8, 2005

First Submitted That Met QC Criteria

December 8, 2005

First Posted (Estimate)

December 12, 2005

Study Record Updates

Last Update Posted (Estimate)

November 18, 2016

Last Update Submitted That Met QC Criteria

November 16, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • U01DA016211 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-Related Disorders

Clinical Trials on Transitional Case Management Study

3
Subscribe